Browse studies

Find your next paid study

7 recruiting studies matching your filters

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (INTERCEPTioN for Suspected Lung Cancer)for Suspected Lung Cancer)

This study evaluates the effectiveness of tumor samples in providing information about hereditary or cancer specific genetic variants that may have a role in d…

Lung CarcinomaMetastatic Malignant Neoplasm in the Lung

Estimated

~$10 – $750

Mayo ClinicNCT06482073

Phase 3

A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in trea…

Metastatic Malignant Neoplasm in the LungMetastatic OsteosarcomaOsteosarcoma

Estimated

~$10 – $7,500

Children's Oncology GroupNCT05235165

Phase 1

Phase I/ II Study of Pulmonary Suffusion to Control Minimal Residual Disease in Resectable or Ablatable Sarcoma or Colorectal Pulmonary Metastases

This phase I/II trial studies the side effects of pulmonary suffusion in controlling minimal residual disease in patients with sarcoma or colorectal carcinoma …

Metastatic Bone SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Soft Tissue Sarcoma+3 more

Estimated

~$10 – $7,500

Roswell Park Cancer InstituteNCT03965234

Observational

Measuring the Effectiveness of a Continuous Positive Airway Pressure (CPAP) Device to Reduce Tumor Motion and Increase Lung Volume Expansion in Patients Undergoing Stereotactic Body Radiotherapy (SBRT) for Tumors That Move With Respiration

This pilot phase I/II trial studies how well a continuous positive airway pressure device or deep inspiration breath hold works in reducing tumor movement in p…

Lung CarcinomaMalignant Respiratory Tract NeoplasmMetastatic Malignant Neoplasm in the Lung

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT03422302

Phase 1

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

This phase I/II trial studies the side effects and possible benefits of NBTXR3, radiation therapy, Anti PD-1 / PD-L1 in treating patients with solid tumor that…

Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+1 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT05039632

Observational

A Single-Arm Phase II Study of Personalized Dose Guidance for Stereotactic Body Radiotherapy (SBRT) in Patients With Lung Tumors

This phase II trial tests the effectiveness and safety of artificial intelligence (AI) to determine dose recommendation during stereotactic body radiation ther…

Lung CarcinomaLung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the Lung+3 more

Estimated

~$10 – $6,250

Northwestern UniversityNCT05802186

Phase 1

A Phase I/II Study Evaluating the Safety and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Lung Cancer During Surgical Procedures

This phase I/II trial studies the best dose and timing of panitumumab-IRDye800 in detecting cancer in participants with lung cancer during the surgery. Panitum…

Lung CarcinomaMetastatic Malignant Neoplasm in the LungStage IV Lung Cancer AJCC v8+2 more

Estimated

~$10 – $6,250

Stanford UniversityNCT03582124